Global next generation sequencing library preparation market report Size, Share, Growth Drivers, Trends, Opportunities & Forecast 2025–2030
Description
Global Next Generation Sequencing Li
ary Preparation Market Overview
The Global Next Generation Sequencing Li
ary Preparation Market is valued at USD 1.75 billion, based on a five-year historical analysis. This growth is primarily driven by rapid advancements in sequencing technology, increased adoption of automation and high-throughput solutions, and the rising prevalence of genetic disorders. The market has seen a surge in investments from both public and private sectors, with significant focus on developing innovative li
ary preparation technologies and integrating artificial intelligence for improved workflow efficiency .
Key players in this market include the United States, Germany, and China, which dominate due to robust healthcare infrastructure, substantial investments in biotechnology, and a high concentration of research institutions. The presence of leading companies and a supportive regulatory environment further contribute to their market leadership, making these countries pivotal in the global landscape of next-generation sequencing .
In 2023, the U.S. government implemented the Genomic Data Sharing Policy, issued by the National Institutes of Health (NIH), which mandates that all genomic data generated from federally funded research must be shared publicly. This regulation, titled "NIH Genomic Data Sharing Policy, 2023," requires compliance with data submission standards and promotes transparency, collaboration among researchers, and accelerated advancements in genomic medicine, thereby fostering innovation in the next-generation sequencing li
ary preparation market .
Global Next Generation Sequencing Li
ary Preparation Market Segmentation
By Type:
The market is segmented into various types of li
ary preparation kits, including DNA Li
ary Preparation Kits, RNA Li
ary Preparation Kits, Target Enrichment Kits, Amplicon-Based Li
ary Preparation Kits, and Others. Among these, DNA Li
ary Preparation Kits are the most dominant due to their extensive application in genomic research, clinical diagnostics, and the increasing focus on personalized medicine. The growing prevalence of genetic disorders and the expansion of genomics-based diagnostics have further propelled the demand for DNA li
ary preparation solutions .
By End-User:
The end-user segmentation includes Academic and Research Institutes, Pharmaceutical and Biotechnology Companies, Clinical and Diagnostic Laboratories, Hospitals and Clinics, and Others. Academic and Research Institutes hold a significant share in the market, driven by the increasing number of research projects focusing on genomics and personalized medicine. The demand for advanced sequencing technologies and high-throughput solutions in these institutions is a key factor contributing to their market leadership .
Global Next Generation Sequencing Li
ary Preparation Market Competitive Landscape
The Global Next Generation Sequencing Li
ary Preparation Market is characterized by a dynamic mix of regional and international players. Leading participants such as Illumina, Inc., Thermo Fisher Scientific Inc., Agilent Technologies, Inc., Roche Sequencing Solutions (F. Hoffmann-La Roche AG), QIAGEN N.V., Bio-Rad Laboratories, Inc., New England Biolabs, Inc., Revvity, Inc. (formerly PerkinElmer, Inc.), Takara Bio Inc., BGI Genomics Co., Ltd., Oxford Nanopore Technologies Ltd., 10x Genomics, Inc., Pacific Biosciences of California, Inc., Genomatix Software GmbH, Stilla Technologies contribute to innovation, geographic expansion, and service delivery in this space.
Illumina, Inc.
1998
San Diego, California, USA
Thermo Fisher Scientific Inc.
2006
Waltham, Massachusetts, USA
Agilent Technologies, Inc.
1999
Santa Clara, California, USA
Roche Sequencing Solutions
2008
Basel, Switzerland
QIAGEN N.V.
1986
Hilden, Germany
Company
Establishment Year
Headquarters
Group Size (Large, Medium, or Small as per industry convention)
Revenue Growth Rate (NGS Li
ary Preparation Segment)
Market Share in NGS Li
ary Preparation
Geographic Presence (Regions/Countries Served)
Product Portfolio
eadth (Number of Li
ary Prep Products)
R&D Investment as % of Revenue
Global Next Generation Sequencing Li
ary Preparation Market Industry Analysis
Growth Drivers
Increasing Demand for Personalized Medicine:
The global personalized medicine market is projected to reach $2.4 trillion by 2024, driven by advancements in genomics and biotechnology. This surge is fueled by the need for tailored therapies, which require precise genomic data. As healthcare systems increasingly adopt personalized approaches, the demand for next-generation sequencing (NGS) li
ary preparation is expected to rise significantly, with an estimated increase in NGS usage by 30% annually in clinical settings.
Advancements in NGS Technology:
The NGS technology landscape is evolving rapidly, with innovations such as improved sequencing accuracy and reduced turnaround times. For instance, the introduction of long-read sequencing technologies has enhanced the ability to analyze complex genomes. In future, the global NGS market is anticipated to exceed $10 billion, reflecting a robust growth trajectory driven by these technological advancements, which are making NGS more accessible and efficient for researchers and clinicians alike.
Rising Investments in Genomic Research:
Global investments in genomic research are projected to surpass $20 billion by 2024, as governments and private sectors recognize the importance of genomics in healthcare. This influx of funding is facilitating the development of advanced NGS li
ary preparation techniques, enabling researchers to conduct more comprehensive studies. The National Institutes of Health (NIH) alone allocated $3.5 billion for genomic research in future, underscoring the commitment to advancing this field and driving market growth.
Market Challenges
High Costs of NGS Li
ary Preparation:
The cost of NGS li
ary preparation can range from $1,000 to $5,000 per sample, which poses a significant barrier for many research institutions and clinical laboratories. This high expense limits the accessibility of NGS technologies, particularly in emerging markets where budget constraints are prevalent. As a result, many potential users may opt for less expensive, traditional sequencing methods, hindering the overall growth of the NGS li
ary preparation market.
Technical Complexity of NGS Workflows:
The technical intricacies involved in NGS workflows can deter adoption among less experienced laboratories. With multiple steps, including sample preparation, li
ary construction, and sequencing, the process requires specialized knowledge and training. In future, it is estimated that 40% of laboratories will face challenges in implementing NGS due to this complexity, which may slow down the market's growth as they seek simpler alternatives.
Global Next Generation Sequencing Li
ary Preparation Market Future Outlook
The future of the NGS li
ary preparation market appears promising, driven by ongoing technological advancements and increasing demand for personalized medicine. As automation becomes more prevalent, laboratories will likely enhance efficiency and reduce costs. Furthermore, the integration of artificial intelligence in data analysis is expected to streamline workflows, making NGS more accessible. These trends indicate a robust growth trajectory, with significant potential for innovation and expansion in various applications, particularly in clinical diagnostics and research.
Market Opportunities
Expansion in Emerging Markets:
Emerging markets, particularly in Asia and Africa, present significant growth opportunities for NGS li
ary preparation. With increasing healthcare investments and a growing focus on genomic research, these regions are expected to see a surge in NGS adoption. By 2024, the demand for NGS services in these markets could increase by over 50%, driven by local initiatives and international collaborations.
Development of Cost-Effective Solutions:
There is a growing need for cost-effective NGS li
ary preparation solutions to make genomic technologies more accessible. Companies that innovate affordable kits and streamlined workflows can capture a significant market share. With the global push towards precision medicine, the demand for these solutions is expected to rise, potentially increasing market penetration by 25% in the next few years.
Please Note: It will take 5-7 business days to complete the report upon order confirmation.
ary Preparation Market Overview
The Global Next Generation Sequencing Li
ary Preparation Market is valued at USD 1.75 billion, based on a five-year historical analysis. This growth is primarily driven by rapid advancements in sequencing technology, increased adoption of automation and high-throughput solutions, and the rising prevalence of genetic disorders. The market has seen a surge in investments from both public and private sectors, with significant focus on developing innovative li
ary preparation technologies and integrating artificial intelligence for improved workflow efficiency .
Key players in this market include the United States, Germany, and China, which dominate due to robust healthcare infrastructure, substantial investments in biotechnology, and a high concentration of research institutions. The presence of leading companies and a supportive regulatory environment further contribute to their market leadership, making these countries pivotal in the global landscape of next-generation sequencing .
In 2023, the U.S. government implemented the Genomic Data Sharing Policy, issued by the National Institutes of Health (NIH), which mandates that all genomic data generated from federally funded research must be shared publicly. This regulation, titled "NIH Genomic Data Sharing Policy, 2023," requires compliance with data submission standards and promotes transparency, collaboration among researchers, and accelerated advancements in genomic medicine, thereby fostering innovation in the next-generation sequencing li
ary preparation market .
Global Next Generation Sequencing Li
ary Preparation Market Segmentation
By Type:
The market is segmented into various types of li
ary preparation kits, including DNA Li
ary Preparation Kits, RNA Li
ary Preparation Kits, Target Enrichment Kits, Amplicon-Based Li
ary Preparation Kits, and Others. Among these, DNA Li
ary Preparation Kits are the most dominant due to their extensive application in genomic research, clinical diagnostics, and the increasing focus on personalized medicine. The growing prevalence of genetic disorders and the expansion of genomics-based diagnostics have further propelled the demand for DNA li
ary preparation solutions .
By End-User:
The end-user segmentation includes Academic and Research Institutes, Pharmaceutical and Biotechnology Companies, Clinical and Diagnostic Laboratories, Hospitals and Clinics, and Others. Academic and Research Institutes hold a significant share in the market, driven by the increasing number of research projects focusing on genomics and personalized medicine. The demand for advanced sequencing technologies and high-throughput solutions in these institutions is a key factor contributing to their market leadership .
Global Next Generation Sequencing Li
ary Preparation Market Competitive Landscape
The Global Next Generation Sequencing Li
ary Preparation Market is characterized by a dynamic mix of regional and international players. Leading participants such as Illumina, Inc., Thermo Fisher Scientific Inc., Agilent Technologies, Inc., Roche Sequencing Solutions (F. Hoffmann-La Roche AG), QIAGEN N.V., Bio-Rad Laboratories, Inc., New England Biolabs, Inc., Revvity, Inc. (formerly PerkinElmer, Inc.), Takara Bio Inc., BGI Genomics Co., Ltd., Oxford Nanopore Technologies Ltd., 10x Genomics, Inc., Pacific Biosciences of California, Inc., Genomatix Software GmbH, Stilla Technologies contribute to innovation, geographic expansion, and service delivery in this space.
Illumina, Inc.
1998
San Diego, California, USA
Thermo Fisher Scientific Inc.
2006
Waltham, Massachusetts, USA
Agilent Technologies, Inc.
1999
Santa Clara, California, USA
Roche Sequencing Solutions
2008
Basel, Switzerland
QIAGEN N.V.
1986
Hilden, Germany
Company
Establishment Year
Headquarters
Group Size (Large, Medium, or Small as per industry convention)
Revenue Growth Rate (NGS Li
ary Preparation Segment)
Market Share in NGS Li
ary Preparation
Geographic Presence (Regions/Countries Served)
Product Portfolio
eadth (Number of Li
ary Prep Products)
R&D Investment as % of Revenue
Global Next Generation Sequencing Li
ary Preparation Market Industry Analysis
Growth Drivers
Increasing Demand for Personalized Medicine:
The global personalized medicine market is projected to reach $2.4 trillion by 2024, driven by advancements in genomics and biotechnology. This surge is fueled by the need for tailored therapies, which require precise genomic data. As healthcare systems increasingly adopt personalized approaches, the demand for next-generation sequencing (NGS) li
ary preparation is expected to rise significantly, with an estimated increase in NGS usage by 30% annually in clinical settings.
Advancements in NGS Technology:
The NGS technology landscape is evolving rapidly, with innovations such as improved sequencing accuracy and reduced turnaround times. For instance, the introduction of long-read sequencing technologies has enhanced the ability to analyze complex genomes. In future, the global NGS market is anticipated to exceed $10 billion, reflecting a robust growth trajectory driven by these technological advancements, which are making NGS more accessible and efficient for researchers and clinicians alike.
Rising Investments in Genomic Research:
Global investments in genomic research are projected to surpass $20 billion by 2024, as governments and private sectors recognize the importance of genomics in healthcare. This influx of funding is facilitating the development of advanced NGS li
ary preparation techniques, enabling researchers to conduct more comprehensive studies. The National Institutes of Health (NIH) alone allocated $3.5 billion for genomic research in future, underscoring the commitment to advancing this field and driving market growth.
Market Challenges
High Costs of NGS Li
ary Preparation:
The cost of NGS li
ary preparation can range from $1,000 to $5,000 per sample, which poses a significant barrier for many research institutions and clinical laboratories. This high expense limits the accessibility of NGS technologies, particularly in emerging markets where budget constraints are prevalent. As a result, many potential users may opt for less expensive, traditional sequencing methods, hindering the overall growth of the NGS li
ary preparation market.
Technical Complexity of NGS Workflows:
The technical intricacies involved in NGS workflows can deter adoption among less experienced laboratories. With multiple steps, including sample preparation, li
ary construction, and sequencing, the process requires specialized knowledge and training. In future, it is estimated that 40% of laboratories will face challenges in implementing NGS due to this complexity, which may slow down the market's growth as they seek simpler alternatives.
Global Next Generation Sequencing Li
ary Preparation Market Future Outlook
The future of the NGS li
ary preparation market appears promising, driven by ongoing technological advancements and increasing demand for personalized medicine. As automation becomes more prevalent, laboratories will likely enhance efficiency and reduce costs. Furthermore, the integration of artificial intelligence in data analysis is expected to streamline workflows, making NGS more accessible. These trends indicate a robust growth trajectory, with significant potential for innovation and expansion in various applications, particularly in clinical diagnostics and research.
Market Opportunities
Expansion in Emerging Markets:
Emerging markets, particularly in Asia and Africa, present significant growth opportunities for NGS li
ary preparation. With increasing healthcare investments and a growing focus on genomic research, these regions are expected to see a surge in NGS adoption. By 2024, the demand for NGS services in these markets could increase by over 50%, driven by local initiatives and international collaborations.
Development of Cost-Effective Solutions:
There is a growing need for cost-effective NGS li
ary preparation solutions to make genomic technologies more accessible. Companies that innovate affordable kits and streamlined workflows can capture a significant market share. With the global push towards precision medicine, the demand for these solutions is expected to rise, potentially increasing market penetration by 25% in the next few years.
Please Note: It will take 5-7 business days to complete the report upon order confirmation.
Table of Contents
97 Pages
- 1. Global next generation sequencing library preparation Size, Share, Growth Drivers, Trends, Opportunities & – Market Overview
- 1.1. Definition and Scope
- 1.2. Market Taxonomy
- 1.3. Market Growth Rate
- 1.4. Market Segmentation Overview
- 2. Global next generation sequencing library preparation Size, Share, Growth Drivers, Trends, Opportunities & – Market Size (in USD Bn), 2019–2024
- 2.1. Historical Market Size
- 2.2. Year-on-Year Growth Analysis
- 2.3. Key Market Developments and Milestones
- 3. Global next generation sequencing library preparation Size, Share, Growth Drivers, Trends, Opportunities & – Market Analysis
- 3.1. Growth Drivers
- 3.1.1. Increasing Demand for Personalized Medicine
- 3.1.2. Advancements in NGS Technology
- 3.1.3. Rising Investments in Genomic Research
- 3.1.4. Growing Applications in Clinical Diagnostics
- 3.2. Restraints
- 3.2.1. High Costs of NGS Library Preparation
- 3.2.2. Technical Complexity of NGS Workflows
- 3.2.3. Regulatory Hurdles in Genomic Testing
- 3.2.4. Data Management and Analysis Issues
- 3.3. Opportunities
- 3.3.1. Expansion in Emerging Markets
- 3.3.2. Development of Cost-Effective Solutions
- 3.3.3. Collaborations with Research Institutions
- 3.3.4. Integration of AI in NGS Processes
- 3.4. Trends
- 3.4.1. Increasing Adoption of Automation in NGS
- 3.4.2. Shift Towards Targeted Sequencing
- 3.4.3. Growth of Cloud-Based Genomic Data Storage
- 3.4.4. Rising Focus on Ethical Considerations in Genomics
- 3.5. Government Regulation
- 3.5.1. Guidelines for Genomic Data Privacy
- 3.5.2. Regulations on Genetic Testing
- 3.5.3. Compliance Standards for NGS Products
- 3.5.4. Funding Initiatives for Genomic Research
- 3.6. SWOT Analysis
- 3.7. Stakeholder Ecosystem
- 3.8. Competition Ecosystem
- 4. Global next generation sequencing library preparation Size, Share, Growth Drivers, Trends, Opportunities & – Market Segmentation, 2024
- 4.1. By Type (in Value %)
- 4.1.1. DNA Library Preparation Kits
- 4.1.2. RNA Library Preparation Kits
- 4.1.3. Target Enrichment Kits
- 4.1.4. Amplicon-Based Library Preparation Kits
- 4.1.5. Others
- 4.2. By End-User (in Value %)
- 4.2.1. Academic and Research Institutes
- 4.2.2. Pharmaceutical and Biotechnology Companies
- 4.2.3. Clinical and Diagnostic Laboratories
- 4.2.4. Hospitals and Clinics
- 4.2.5. Others
- 4.3. By Application (in Value %)
- 4.3.1. Drug & Biomarker Discovery
- 4.3.2. Oncology
- 4.3.3. Infectious Diseases
- 4.3.4. Genetic Disorders
- 4.3.5. Reproductive Health
- 4.4. By Component (in Value %)
- 4.4.1. Reagents & Consumables
- 4.4.2. Instruments
- 4.4.3. Software & Services
- 4.4.4. Others
- 4.5. By Sales Channel (in Value %)
- 4.5.1. Direct Sales
- 4.5.2. Distributors
- 4.5.3. Online Sales
- 4.5.4. Others
- 4.6. By Region (in Value %)
- 4.6.1. North India
- 4.6.2. South India
- 4.6.3. East India
- 4.6.4. West India
- 4.6.5. Central India
- 4.6.6. Northeast India
- 4.6.7. Union Territories
- 5. Global next generation sequencing library preparation Size, Share, Growth Drivers, Trends, Opportunities & – Market Cross Comparison
- 5.1. Detailed Profiles of Major Companies
- 5.1.1. Illumina, Inc.
- 5.1.2. Thermo Fisher Scientific Inc.
- 5.1.3. Agilent Technologies, Inc.
- 5.1.4. Roche Sequencing Solutions (F. Hoffmann-La Roche AG)
- 5.1.5. QIAGEN N.V.
- 5.2. Cross Comparison Parameters
- 5.2.1. Revenue Growth Rate (NGS Library Preparation Segment)
- 5.2.2. Market Share in NGS Library Preparation
- 5.2.3. Geographic Presence (Regions/Countries Served)
- 5.2.4. Product Portfolio Breadth (Number of Library Prep Products)
- 5.2.5. R&D Investment as % of Revenue
- 6. Global next generation sequencing library preparation Size, Share, Growth Drivers, Trends, Opportunities & – Market Regulatory Framework
- 6.1. Industry Standards
- 6.2. Compliance Requirements and Audits
- 6.3. Certification Processes
- 7. Global next generation sequencing library preparation Size, Share, Growth Drivers, Trends, Opportunities & – Market Future Size (in USD Bn), 2025–2030
- 7.1. Future Market Size Projections
- 7.2. Key Factors Driving Future Market Growth
- 8. Global next generation sequencing library preparation Size, Share, Growth Drivers, Trends, Opportunities & – Market Future Segmentation, 2030
- 8.1. By Type (in Value %)
- 8.2. By End-User (in Value %)
- 8.3. By Application (in Value %)
- 8.4. By Component (in Value %)
- 8.5. By Sales Channel (in Value %)
- 8.6. By Region (in Value %)
- Disclaimer
- Contact Us
Pricing
Currency Rates
Questions or Comments?
Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.
